1-4 of 4
Yan Beauverd, MD
Close
Sort by
Journal Articles

The AML EBMT Cytogenetic Risk Score for Acute Myeloid Leukaemia (AML) Is Prognostic for Outcomes of Allogeneic Stem Cell (HSCT)

Yan Beauverd, MD, Sarah Morin, MD PhD, Mitja Nabergoj, Caroline Stephan, Carmen De Ramon Ortiz, MD, Anne-Claire Mamez, MD, Elif Mahne, MD, Anna Petropoulou, MD, Federica Giannotti, MD, Federico Simonetta, MDPhD, Christian Ayer, MD, Benjamin Bruno, MD, Laura Bounaix, MD, Maria Anastasiou, MD, Maria Mappoura, MD, Thien-An Tran, MD, Stavroula Masouridi-Levrat, MD, Yves Chalandon, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-140010
Published: 2020
Journal Articles

Impact of Different T Cell Depletion Protocols on Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation

Amandine Pradier, PhD, Adrien Petitpas, Anne-Claire Mamez, MD, Federica Giannotti, MD, Sarah Morin, MD PhD, Elif Mahne, MD, Yan Beauverd, MD, Mitja Nabergoj, Carmen De Ramon Ortiz, MD, Maria Anastasiou, MD, Maria Mappoura, MD, Thien-An Tran, MD, Christian Ayer, MD, Anna Petropoulou, MD, Benjamin Bruno, MD, Paraskevi Stakia, MD, Laura Bounaix, MD, Stavroula Masouridi-Levrat, MD, Federico Simonetta, MDPhD, Yves Chalandon, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-139208
Published: 2020
Journal Articles

Efficient Prophylaxis with Defibrotide for Sinusoidal Obstruction Syndrome (SOS) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Yves Chalandon, MD, Federico Simonetta, MD PhD, Carole Dantin, MSc, Aikaterini Koutsi, MD, Anne-Claire Mamez, MD, Yan Beauverd, MD, Olga Tsopra, MD, Audrey Simon, MD, Stijn Bex, MD, Caroline Stephan, MD, Juan Felipe Rodriguez Morales, MD, Karolina Polchlopek, MD, Marc Ansari, MD, Yordanka Tirefort, MD, Eddy Roosnek, PhD, Stavroula Masouridi-Levrat, MD
Journal: Blood
Blood (2016) 128 (22): 2204.
https://doi.org/10.1182/blood.V128.22.2204.2204
Published: 2016
Journal Articles

T-Cell Depletion Improves the Composite End Point Graft-Versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Federico Simonetta, MD PhD, Stavroula Masouridi-Levrat, MD, Yan Beauverd, MD, Olga Tsopra, MD, Yordanka Tirefort, MD, Caroline Stephan, MD, Karolina Polchlopek, MD, Riccardo Favale, MD, Carole Dantin, MSc, Marc Ansari, MD, Eddy Roosnek, PhD, Yves Chalandon
Journal: Blood
Blood (2015) 126 (23): 3204.
https://doi.org/10.1182/blood.V126.23.3204.3204
Published: 2015